Allergan

Latest stories

14h
The Economic Times
DRL, Cipla, Aurobindo among others to buy products from Tevaand assets related to 79 pharmaceutical products to settle FTC charges that its
DRL, Cipla, Aurobindo among others to buy products from Teva
The Economic Times / Posted 14 hours ago
and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan plc's generic pharmaceutical business would be anti-competitive. The remedy requires Teva to divest the drug... Read more
3 related stories
2d
TheBull
Dow flat as Fed keeps rates low; Apple lifts Nasdaqpercent from a year ago and only slightly more than the 310 million in the past
Dow flat as Fed keeps rates low; Apple lifts Nasdaq
TheBull / Posted 2 days ago
percent from a year ago and only slightly more than the 310 million in the past quarter. In non-earnings news, drugmaker Allergan rose 4.5 percent after US antitrust regulators approved the sale of its generic drugs business for $40.5 billion to... Read more
3 related stories
2d
Orange County Business Journal
Mazzo to German Device Makereye device startup AcuFocus Inc., and has more than 35 years of experience in t
Mazzo to German Device Maker
Orange County Business Journal / Posted 2 days ago
eye device startup AcuFocus Inc., and has more than 35 years of experience in the ophthalmic field, including 22 years with Allergan Inc. [now Allergan PLC]. AcuFocus said separately today that it appointed Alan Waterhouse as its president and... Read more
2d
Business Wire
Chase Pharmaceuticals Presents Phase 2 Results for CPC-201 at 2016 Alzheimer’s Association International ConferenceRoche and Otsuka. Chase is led by its chief executive officer and president, Do
Chase Pharmaceuticals Presents Phase 2 Results for CPC-201 at 2016 Alzheimer’s Association International Conference
Business Wire / Posted 2 days ago
Roche and Otsuka. Chase is led by its chief executive officer and president, Douglas Ingram, formerly the president of Allergan, Inc. Chase has closed over $24 million in funding to date, with approximately $22 million through a Series B... Read more
2d
Channel NewsAsia
Teva purchase of Allergan generics business gets OK with conditionsWASHINGTON: Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to p
Teva purchase of Allergan generics business gets OK with conditions
Channel NewsAsia / Posted 2 days ago
WASHINGTON: Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest more than 75 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The US$40.5... Read more
3 related stories
2d
Reuters
Teva purchase of Allergan generics business gets OK with conditionsJerusalem March 23, 2010. WASHINGTON Teva Pharmaceutical Industries Ltd (TEVA.
Teva purchase of Allergan generics business gets OK with conditions
Reuters / Posted 2 days ago
Jerusalem March 23, 2010. WASHINGTON Teva Pharmaceutical Industries Ltd (TEVA.TA) won U.S. antitrust approval to purchase Allergan Plc's (AGN.N) generics business, after agreeing to divest more than 75 generic drugs to rival firms, the Federal... Read more
3 related stories
3d
Reuters
Teva, Mylan eye Pfizer's Brazil venture, sources saydecades has slowed sales. Pfizer will decide this year whether to globally exit
Teva, Mylan eye Pfizer's Brazil venture, sources say
Reuters / Posted 3 days ago
decades has slowed sales. Pfizer will decide this year whether to globally exit generic drugs, after plans to buy rival Allergan Inc collapsed. Generic drug sales in Brazil, Latin America's largest economy, expanded 10 percent last year,... Read more
3d
Channel NewsAsia
Teva, Mylan eye Pfizer's Brazil venture, sources saydecades has slowed sales. Pfizer will decide this year whether to globally exit
Teva, Mylan eye Pfizer's Brazil venture, sources say
Channel NewsAsia / Posted 3 days ago
decades has slowed sales. Pfizer will decide this year whether to globally exit generic drugs, after plans to buy rival Allergan Inc collapsed. Generic drug sales in Brazil, Latin America's largest economy, expanded 10 percent last year,... Read more
4d
AdWeek
Rauxa, the Industry's Largest Woman-Owned Agency, Names First Chief Creative Officerto include six offices and 230 employees across the United States. Its current
Rauxa, the Industry's Largest Woman-Owned Agency, Names First Chief Creative Officer
AdWeek / Posted 4 days ago
to include six offices and 230 employees across the United States. Its current client list includes Gap, Alaska Airlines, Allergan, Blue Shield of California and Verizon, which consolidated direct marketing duties for the FiOS portion of its... Read more
4d
CNBC
Credit Suisse says Allergan's drug pipeline is 'underappreciated'Credit Suisse analysts Monday initiated shares of Allergan at an "outperform" r
Credit Suisse says Allergan's drug pipeline is 'underappreciated'
CNBC / Posted 4 days ago
Credit Suisse analysts Monday initiated shares of Allergan at an "outperform" rating, saying the drugmaker's diversified drug pipeline is "underappreciated" by investors. "We see it as a company with a broad and underappreciated pipeline that will... Read more
4d
KECI Missoula
Recent big mergers and acquisitionsblocked a merger of the two office suppliers back in 1997. In one of the bigge
Recent big mergers and acquisitions
KECI Missoula / Posted 4 days ago
blocked a merger of the two office suppliers back in 1997. In one of the biggest proposed corporate deals ever, Pfizer and Allergan announced on Nov. 23, 2015, that they would combine to create the world's largest pharmaceutical giant. The merger,... Read more
5d
AdWeek
50 Creatives Whose Brilliant Ideas and Beautiful Craft Will Make You JealousJordan at Wieden + Kennedy. At BSSP, he's been part of a major creative win on
50 Creatives Whose Brilliant Ideas and Beautiful Craft Will Make You Jealous
AdWeek / Posted 5 days ago
Jordan at Wieden + Kennedy. At BSSP, he's been part of a major creative win on Uber and helped the agency add work from Allergan and PowerBar. "Part of our responsibility is figuring out how to infuse culturally relevant thinking into what our... Read more
5d
Business Standard India
Aurobindo gets ready to play with the big boysIndustries’ offer to divest overlapping assets in the UK, Ireland and Iceland —
Aurobindo gets ready to play with the big boys
Business Standard India / Posted 5 days ago
Industries’ offer to divest overlapping assets in the UK, Ireland and Iceland — a precondition for acquisition of Allergan Plc's generics business, put by the European authorities — comes as Aurobindo’s oral solid finished dosage facility... Read more
5d
Business Standard India
Aurobindo set for big league with Teva Europe asset acquisitionLimited's offer to divest the overlapping assets in the UK, Ireland and Iceland
Aurobindo set for big league with Teva Europe asset acquisition
Business Standard India / Posted 5 days ago
Limited's offer to divest the overlapping assets in the UK, Ireland and Iceland-a precondition for acquisition of Allergan Plc's generics business, put by the European authorities- comes at a time Aurobindo's new oral solid finished dosage... Read more
7d
Business Wire
Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'facilities, is expected to be used to fund the pending acquisition of the gener
Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'
Business Wire / Posted 7 days ago
facilities, is expected to be used to fund the pending acquisition of the generic pharmaceuticals business (Actavis Gx) of Allergan plc (NYSE: AGN; 'BBB-'/Stable). A full list of ratings, which apply to approximately $30 billion of outstanding... Read more
7d
The Age
Mayne knocking on the door of ASX100 inclusionis upgrading its US production capacity, which is due to be completed in 2018.
Mayne knocking on the door of ASX100 inclusion
The Age / Posted 7 days ago
is upgrading its US production capacity, which is due to be completed in 2018. The drugs are being acquired from Teva and Allergan ahead of the planned merger of the two companies, which has prompted the US government to push for the sales before... Read more
7d
Sydney Morning Herald
Mayne knocking on the door of ASX100 inclusionis upgrading its US production capacity, which is due to be completed in 2018.
Mayne knocking on the door of ASX100 inclusion
Sydney Morning Herald / Posted 7 days ago
is upgrading its US production capacity, which is due to be completed in 2018. The drugs are being acquired from Teva and Allergan ahead of the planned merger of the two companies, which has prompted the US government to push for the sales before... Read more
8d
Pacific Coast Business Times
Amgen settles lawsuit, says biosimilar works as well as Herceptinnot admit fault and said in a news release the company believes the suit has no
Amgen settles lawsuit, says biosimilar works as well as Herceptin
Pacific Coast Business Times / Posted 8 days ago
not admit fault and said in a news release the company believes the suit has no merit. On July 21, Amgen and Dublin-based Allergan released positive news about biosimilar ABP 980. Biosimilars are new, lower-cost treatments and similar to generics... Read more
3 related stories
8d
Business Wire
Teva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Genericsthe USD and Eurobond offerings) towards the cash portion of the purchase price
Teva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
Business Wire / Posted 8 days ago
the USD and Eurobond offerings) towards the cash portion of the purchase price for its previously announced acquisition of Allergan plc’s worldwide generic pharmaceuticals business (“Actavis Generics”), to pay related fees and expenses, and/or... Read more
4 related stories
8d
FOX Business
M&A Breakdown: Record Number of Failed U.S. Deals So Far in 2016have turned to rubble. Among the blockbuster tie-ups failing to materialize we
M&A Breakdown: Record Number of Failed U.S. Deals So Far in 2016
FOX Business / Posted 8 days ago
have turned to rubble. Among the blockbuster tie-ups failing to materialize were a $160 billion proposed deal between Allergan (NYSE:AGN) and Pfizer (NYSE:PFE); a $102 billion proposal between United Technologies (NYSE:UTX) and Honeywell... Read more
166 related stories
8d
Newsmax
Copycat Version of Cancer Drug Herceptin Found EffectiveAmgen Inc and Allergan Plc said their copycat version of Roche Holding AG's blo
Copycat Version of Cancer Drug Herceptin Found Effective
Newsmax / Posted 8 days ago
Amgen Inc and Allergan Plc said their copycat version of Roche Holding AG's blockbuster cancer treatment, Herceptin, was found as effective as the original in a late-stage study. There were no "clinically meaningful" differences in data gathered... Read more
8d
Swissinfo
Teva Markets Swiss-Franc Bonds in Worldwide Fundraising Sweepbillion) in a three-part offering, it said. It has already sold dollar- and eur
Teva Markets Swiss-Franc Bonds in Worldwide Fundraising Sweep
Swissinfo / Posted 8 days ago
billion) in a three-part offering, it said. It has already sold dollar- and euro-denominated notes to help its purchase of Allergan Plc’s generic-drug business. Teva has accelerated a roughly $20 billion fundraising program to take advantage of... Read more
9d
CNBC
A red hot realty stockrapid speed: Synergy Pharmaceuticals: "I too am frustrated with the situation.
A red hot realty stock
CNBC / Posted 9 days ago
rapid speed: Synergy Pharmaceuticals: "I too am frustrated with the situation. I do not think that Brent Saunders [CEO of Allergan] is going to bite on that. I do believe that the Allergan money [from Teva] is going to come in within the next... Read more
9d
CNBC
Why Facebook is beating Snapchatstocks: Synergy Pharmaceuticals: "I too am frustrated with the situation. I do
Why Facebook is beating Snapchat
CNBC / Posted 9 days ago
stocks: Synergy Pharmaceuticals: "I too am frustrated with the situation. I do not think that Brent Saunders [CEO of Allergan] is going to bite on that. I do believe that the Allergan money [from Teva] is going to come in within the next... Read more
9d
Business Wire
Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'the proceeds of which are expected to fund the pending acquisition of the gener
Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'
Business Wire / Posted 9 days ago
the proceeds of which are expected to fund the pending acquisition of the generic pharmaceuticals business (Actavis Gx) of Allergan plc (NYSE: AGN; 'BBB-'/Stable). A full list of ratings, which apply to approximately $10 billion of debt... Read more
4 related stories
10d
Reuters
SoftBank bid for ARM catches some hedge funds off guardof the takeover bid, up from 2 percent in January. Earlier this year, Maverick
SoftBank bid for ARM catches some hedge funds off guard
Reuters / Posted 10 days ago
of the takeover bid, up from 2 percent in January. Earlier this year, Maverick also nearly doubled its stake in drugmaker Allergan (AGN.N) before a planned $150 billion deal with Pfizer (PFE.N) unravelled and Allergan's stock dropped. Hedge funds... Read more
10d
Channel NewsAsia
SoftBank bid for ARM catches some hedge funds off guardof the takeover bid, up from 2 percent in January. Earlier this year, Maverick
SoftBank bid for ARM catches some hedge funds off guard
Channel NewsAsia / Posted 10 days ago
of the takeover bid, up from 2 percent in January. Earlier this year, Maverick also nearly doubled its stake in drugmaker Allergan before a planned US$150 billion deal with Pfizer unravelled and Allergan's stock dropped. Hedge funds who buy and... Read more
10d
The Economic Times
Teva Pharma prices $15 bln in notes to fund Allergan generics dealon Tuesday it successfully priced a debt offering for $15 billion worth of seni
Teva Pharma prices $15 bln in notes to fund Allergan generics deal
The Economic Times / Posted 10 days ago
on Tuesday it successfully priced a debt offering for $15 billion worth of senior notes to help fund its acquisition of Allergan Plc's generic drug business. The fixed-rate notes mature between 2018 and 2046. Additional senior, unsecured... Read more
10d
Business Wire
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Genericsnet proceeds from this offering towards the cash portion of the purchase price
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
Business Wire / Posted 10 days ago
net proceeds from this offering towards the cash portion of the purchase price for its previously announced acquisition of Allergan plc’s worldwide generic pharmaceuticals business (“Actavis Generics”), to pay related fees and expenses, and/or... Read more
11d
CNBC
This battleground stock defies current wisdomto give it to them. These guys are among the best business people in America."
This battleground stock defies current wisdom
CNBC / Posted 11 days ago
to give it to them. These guys are among the best business people in America." Teva Pharmaceuticals: "No, I want to be in Allergan because that is who they are paying to get the big generic business. I think that deal uis going to happen any day... Read more
11d
The Arizona Republic
5 things we learned about money in Arizona's congressional racesGrijalva’s benefactor was the Ak-Chin Indian Community. Schweikert’s affiliate
5 things we learned about money in Arizona's congressional races
The Arizona Republic / Posted 11 days ago
Grijalva’s benefactor was the Ak-Chin Indian Community. Schweikert’s affiliated PAC collected from a PAC controlled by Allergan, a New Jersey-based pharmaceutical giant that collected $150 million when its merger efforts with Pfizer failed... Read more
14d
Accounting Today
Treasury Corporate-Debt Rules Exceed Authority, Tax Lawyers Saymeasure—one aimed at preventing serial inversions—effectively killed a planned
Treasury Corporate-Debt Rules Exceed Authority, Tax Lawyers Say
Accounting Today / Posted 14 days ago
measure—one aimed at preventing serial inversions—effectively killed a planned $160 billion merger between Pfizer Inc. and Allergan Plc. That deal would have created a new company with a tax address in Ireland, where the corporate tax rate is 12.5... Read more
2 related stories
14d
The Irish Times
Ireland’s GDP figures: Why 26% economic growth is a problemfirm Medtronic, which moved to Ireland through a merger with rival Covidien in
Ireland’s GDP figures: Why 26% economic growth is a problem
The Irish Times / Posted 14 days ago
firm Medtronic, which moved to Ireland through a merger with rival Covidien in a deal worth $48 billion. US botox maker Allergan also transferred its headquarters to Ireland via a reverse takeover of Irish-based drug maker Actavis in a deal... Read more
12 related stories
15d
Channel NewsAsia
Business interests hit US Treasury curb on overseas tax dealsstripping curbs and other steps meant to combat inversions, drugmaker Pfizer en
Business interests hit US Treasury curb on overseas tax deals
Channel NewsAsia / Posted 15 days ago
stripping curbs and other steps meant to combat inversions, drugmaker Pfizer ended a US$160-billion agreement to acquire Allergan Inc and move to its home country of Ireland. The Treasury hearing could be the last chance for the public to... Read more
2 related stories
15d
Reuters
Business interests hit U.S. Treasury curb on overseas tax dealsstripping curbs and other steps meant to combat inversions, drugmaker Pfizer en
Business interests hit U.S. Treasury curb on overseas tax deals
Reuters / Posted 15 days ago
stripping curbs and other steps meant to combat inversions, drugmaker Pfizer ended a $160-billion agreement to acquire Allergan Inc and move to its home country of Ireland. The Treasury hearing could be the last chance for the public to... Read more
2 related stories
15d
Business Insider
Turns out nobody ever really wanted Bill Ackman at Valeantin an amended complaint to the ongoing lawsuit between Ackman's Pershing Square
Turns out nobody ever really wanted Bill Ackman at Valeant
Business Insider / Posted 15 days ago
in an amended complaint to the ongoing lawsuit between Ackman's Pershing Square hedge fund, Valeant, and investors in Allergan Pharmaceuticals. It must've been love Valeant tried to acquire Allergan with Ackman's help back in 2014, and now... Read more
15d
Reuters
Teva Pharma to raise $20 billion to $25 billion in bond sale next weekIndustries (TEVA.TA) will raise between $20 billion and $25 billion next week t
Teva Pharma to raise $20 billion to $25 billion in bond sale next week
Reuters / Posted 15 days ago
Industries (TEVA.TA) will raise between $20 billion and $25 billion next week to finance its $40 billion acquisition of Allergan Plc's (AGN.N) generics business, the Globes financial news website said on Thursday. Israel-based Teva (TEVA.N)... Read more
15d
WA Today
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackmanwrote about it on his blog in June of that year. Ackman's Pershing first teamed
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackman
WA Today / Posted 15 days ago
wrote about it on his blog in June of that year. Ackman's Pershing first teamed up with Valeant on an unsuccessful bid for Allergan Inc in April 2014. The drug maker's stock ended last week at $US23.25, after months of turmoil including US federal... Read more
28 related stories
15d
Brisbane Times
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackmanwrote about it on his blog in June of that year. Ackman's Pershing first teamed
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackman
Brisbane Times / Posted 15 days ago
wrote about it on his blog in June of that year. Ackman's Pershing first teamed up with Valeant on an unsuccessful bid for Allergan Inc in April 2014. The drug maker's stock ended last week at $US23.25, after months of turmoil including US federal... Read more
28 related stories
15d
Boston Globe
Gilead dodges nearly $10 billion in US taxesrecently issued new rules to thwart such deals, known as tax inversions, prompt
Gilead dodges nearly $10 billion in US taxes
Boston Globe / Posted 15 days ago
recently issued new rules to thwart such deals, known as tax inversions, prompting Pfizer to scuttle a plan to acquire Allergan. The latest critique also arrives as Gilead undergoes sustained criticism over its pricing practices. In 2013, the... Read more
2 related stories
16d
Fortune
This Tax Haven Just Revised Its 2015 GDP up From 7.8% to 26.3%behind several notable recent mergers and acquisitions, such as the attempted $
This Tax Haven Just Revised Its 2015 GDP up From 7.8% to 26.3%
Fortune / Posted 16 days ago
behind several notable recent mergers and acquisitions, such as the attempted $160 billion deal between U.S.-based Allergan to the smaller, Ireland-based Pfizer, or the 2013 acquisition of Irish biotech firm, Elan, by Perrigo for $8.6... Read more
16d
The Age
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackmanwrote about it on his blog in June of that year. Ackman's Pershing first teamed
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackman
The Age / Posted 16 days ago
wrote about it on his blog in June of that year. Ackman's Pershing first teamed up with Valeant on an unsuccessful bid for Allergan Inc in April 2014. The drug maker's stock ended last week at $US23.25, after months of turmoil including US federal... Read more
28 related stories
16d
Sydney Morning Herald
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackmanwrote about it on his blog in June of that year. Ackman's Pershing first teamed
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackman
Sydney Morning Herald / Posted 16 days ago
wrote about it on his blog in June of that year. Ackman's Pershing first teamed up with Valeant on an unsuccessful bid for Allergan Inc in April 2014. The drug maker's stock ended last week at $US23.25, after months of turmoil including US federal... Read more
28 related stories
16d
Canberra Times
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackmanwrote about it on his blog in June of that year. Ackman's Pershing first teamed
John Hempton, the Aussie fraud-hunting short seller taunting billionaire investor Bill Ackman
Canberra Times / Posted 16 days ago
wrote about it on his blog in June of that year. Ackman's Pershing first teamed up with Valeant on an unsuccessful bid for Allergan Inc in April 2014. The drug maker's stock ended last week at $US23.25, after months of turmoil including US federal... Read more
4 related stories
16d
Newsmax
Longtime Valeant Investor Sequoia Fund Exits After Lossesat midyear from 38 at the start of 2016, exiting positions including diagnostic
Longtime Valeant Investor Sequoia Fund Exits After Losses
Newsmax / Posted 16 days ago
at midyear from 38 at the start of 2016, exiting positions including diagnostics firm Idexx Laboratories Inc., drugmaker Allergan Plc and outdoor retailer Cabela’s Inc. Sequoia reopened to new direct investors in April. It’s working with... Read more
4 related stories
16d
FOX Business
Wall St Record-Setting Rally Peters Outwhich held back in the past couple of days. The energy index dropped 1.4 perce
Wall St Record-Setting Rally Peters Out
FOX Business / Posted 16 days ago
which held back in the past couple of days. The energy index dropped 1.4 percent after a steep fall in crude prices. Allergan rose 2.3 percent to $245.2 after Teva said it expected its $40 billion to buy Allergan's generics business would... Read more
69 related stories
16d
FOX Business
Wall St Record-Setting Rally Peters Outwhich held back in the past couple of days. The energy index dropped 1.4 perce
Wall St Record-Setting Rally Peters Out
FOX Business / Posted 16 days ago
which held back in the past couple of days. The energy index dropped 1.4 percent after a steep fall in crude prices. Allergan rose 2.3 percent to $245.2 after Teva said it expected its $40 billion to buy Allergan's generics business would... Read more
69 related stories
16d
Fortune
Teva Says Its Deal to Buy Allergan's Generics Business Will Close 'Any Time'Teva Pharmaceuticals teva said on Wednesday it expected its $40 billion deal to
Teva Says Its Deal to Buy Allergan's Generics Business Will Close 'Any Time'
Fortune / Posted 16 days ago
Teva Pharmaceuticals teva said on Wednesday it expected its $40 billion deal to buy Allergan’s agn generics business to close “any time,” even as the companies extended the deadline for completing the transaction to October to allow more time for... Read more
16d
Herald Sun
S&P 500, Dow ease back after highswere higher, led by a 0.6 per cent rise in utilities. However, healthcare stoc
S&P 500, Dow ease back after highs
Herald Sun / Posted 16 days ago
were higher, led by a 0.6 per cent rise in utilities. However, healthcare stocks gave the biggest boost to the S&P. Allergan rose 1.4 per cent, after CNBC reported that its merger deal with Teva was expected to be approved in the next two... Read more
69 related stories
16d
Weekly Times
S&P 500, Dow ease back after highswere higher, led by a 0.6 per cent rise in utilities. However, healthcare stoc
S&P 500, Dow ease back after highs
Weekly Times / Posted 16 days ago
were higher, led by a 0.6 per cent rise in utilities. However, healthcare stocks gave the biggest boost to the S&P. Allergan rose 1.4 per cent, after CNBC reported that its merger deal with Teva was expected to be approved in the next two... Read more
69 related stories
More

People in this news